Wednesday, 08 February 2017 08:30

Recall of hydrocortisone 100mg/1 ml solution

Rate this item
(4 votes)

The attention of the agency has been drawn to the recall of a batch of Hydrocortisone injection as a precaution following the receipt of a number of complaints that the solution in some ampoules has a yellowish appearance. Hydrocortisone injection is used to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). It is also used to treat severe allergic reactions. Hydrocortisone injection is used in the management of multiple sclerosis (a disease in which the nerves do not function properly), lupus (a disease in which the body attacks many of its own organs), gastrointestinal disease, and certain types of arthritis. It is also used to treat certain conditions that affect the blood, skin, eyes, nervous system, thyroid, kidneys, and lungs. Hydrocortisone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.

PRODUCT DETAILS

Name of Product: Hydrocortisone Injection

Affected Batch No: 039268

Expiry date: August 2017

Healthcare Provider’s action

Healthcare provider should quarantine any offending ampoules

Report adverse events or side effects related to the use of the product to NAFDAC PRASCOR (20543, toll free from all network) or via individual case safety report forms or via This email address is being protected from spambots. You need JavaScript enabled to view it. and also encourage patients to do same.

NAFDAC………Safeguarding the Health of the Nation!!!

Read 5040 times Last modified on Wednesday, 08 February 2017 08:38

CORPORATE LINKS